受体阻滞剂-话题@MedSci

#受体阻滞剂#

148篇内容 | 3267人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995117, encodeId=52f0199511ed0, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JACC Heart Fail：急性失代偿性心衰(ADHF)患者β受体阻滞剂治疗不能停, objectType=article, longId=54663, objectId=85c85466365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85c85466365, replyNumber=0, likeNumber=69, createdTime=2016-04-30, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85c85466365, moduleTitle=JACC Heart Fail：急性失代偿性心衰(ADHF)患者β受体阻滞剂治疗不能停, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85c85466365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995114, encodeId=d341199511478, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, objectType=article, longId=49414, objectId=79a64941446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a64941446, replyNumber=0, likeNumber=67, createdTime=2016-02-02, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a64941446, moduleTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79a64941446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995119, encodeId=e85c19951199a, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=BMJ:β受体阻滞剂可减少COPD的急性发作, objectType=article, longId=55494, objectId=b3d655494a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3d655494a6, replyNumber=0, likeNumber=93, createdTime=2016-02-28, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3d655494a6, moduleTitle=BMJ:β受体阻滞剂可减少COPD的急性发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3d655494a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995115, encodeId=39b8199511500, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Circulation：冠脉搭桥手术后的病人长期服用β受体阻滞剂有无必要？, objectType=article, longId=50920, objectId=d64a50920ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64a50920ad, replyNumber=0, likeNumber=70, createdTime=2015-12-08, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64a50920ad, moduleTitle=Circulation：冠脉搭桥手术后的病人长期服用β受体阻滞剂有无必要？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64a50920ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995111, encodeId=61f71995111b8, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用, objectType=article, longId=36573, objectId=5ddf365e3ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ddf365e3ff, replyNumber=0, likeNumber=62, createdTime=2015-03-08, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ddf365e3ff, moduleTitle=JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ddf365e3ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995110, encodeId=b94c199511029, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险, objectType=article, longId=36147, objectId=74c73614e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74c73614e97, replyNumber=0, likeNumber=64, createdTime=2015-05-12, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74c73614e97, moduleTitle=Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74c73614e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995109, encodeId=044019951096c, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战, objectType=article, longId=31306, objectId=f9ea3130654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ea3130654, replyNumber=0, likeNumber=58, createdTime=2014-10-01, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ea3130654, moduleTitle=Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ea3130654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995113, encodeId=88f9199511394, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效, objectType=article, longId=41026, objectId=d9824102628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9824102628, replyNumber=0, likeNumber=62, createdTime=2015-06-11, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9824102628, moduleTitle=CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9824102628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995108, encodeId=ac081995108a2, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？, objectType=article, longId=28804, objectId=48aa2880427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48aa2880427, replyNumber=0, likeNumber=66, createdTime=2014-12-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48aa2880427, moduleTitle=孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48aa2880427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995112, encodeId=9090199511269, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=郭艺芳：β受体阻滞剂不会走下神坛, objectType=article, longId=37838, objectId=821e3e838ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=821e3e838ef, replyNumber=0, likeNumber=0, createdTime=2015-02-11, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=821e3e838ef, moduleTitle=郭艺芳：β受体阻滞剂不会走下神坛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=821e3e838ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995106, encodeId=f15019951061e, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, objectType=article, longId=28410, objectId=52282841047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52282841047, replyNumber=0, likeNumber=74, createdTime=2014-10-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52282841047, moduleTitle=Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52282841047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995107, encodeId=ecb3199510e90, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, objectType=article, longId=28725, objectId=acd428e2528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acd428e2528, replyNumber=0, likeNumber=67, createdTime=2014-08-16, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acd428e2528, moduleTitle=黄峻：JNC8不能否认β受体阻滞剂的“中国特色”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acd428e2528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995104, encodeId=30e6199510414, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=2013 β受体阻滞剂在高血压应用中的专家指导建议, objectType=article, longId=20773, objectId=ee5020e7340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5020e7340, replyNumber=0, likeNumber=62, createdTime=2013-11-05, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5020e7340, moduleTitle=2013 β受体阻滞剂在高血压应用中的专家指导建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5020e7340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995105, encodeId=c4ff1995105b1, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, objectType=article, longId=27315, objectId=c61a2e315da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61a2e315da, replyNumber=0, likeNumber=61, createdTime=2013-11-30, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61a2e315da, moduleTitle=JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61a2e315da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995103, encodeId=cc19199510342, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAMA：非心脏手术围手术期使用β-受体阻滞剂或可降低患者死亡率, objectType=article, longId=17769, objectId=1b141e76998, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b141e76998, replyNumber=0, likeNumber=52, createdTime=2013-05-28, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b141e76998, moduleTitle=JAMA：非心脏手术围手术期使用β-受体阻滞剂或可降低患者死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b141e76998)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995100, encodeId=f97c19951000a, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=β受体阻滞剂不影响慢性肾病死亡率, objectType=article, longId=13153, objectId=cda1131536b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda1131536b, replyNumber=0, likeNumber=79, createdTime=2013-03-07, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda1131536b, moduleTitle=β受体阻滞剂不影响慢性肾病死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda1131536b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995099, encodeId=7e04199509970, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠, objectType=article, longId=10972, objectId=f43a109e2b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f43a109e2b3, replyNumber=0, likeNumber=74, createdTime=2013-04-22, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f43a109e2b3, moduleTitle=SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f43a109e2b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995102, encodeId=d6a21995102e2, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, objectType=article, longId=17412, objectId=8f1e1e412de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f1e1e412de, replyNumber=0, likeNumber=69, createdTime=2013-08-25, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f1e1e412de, moduleTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f1e1e412de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995101, encodeId=a5e6199510110, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤, objectType=article, longId=14661, objectId=b1d51466163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1d51466163, replyNumber=0, likeNumber=60, createdTime=2013-04-12, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1d51466163, moduleTitle=对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1d51466163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995098, encodeId=3df61995098b2, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=β受体阻滞剂有待深入研究, objectType=article, longId=7280, objectId=d6a3e280ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6a3e280ee, replyNumber=0, likeNumber=83, createdTime=2012-07-01, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6a3e280ee, moduleTitle=β受体阻滞剂有待深入研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6a3e280ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

受体阻滞剂

2020-05-29

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JACC Heart Fail：急性失代偿性心衰(ADHF)患者β受体阻滞剂治疗不能停

2016-04-30

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？

2016-02-02

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

BMJ:β受体阻滞剂可减少COPD的急性发作

2016-02-28

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Circulation：冠脉搭桥手术后的病人长期服用β受体阻滞剂有无必要？

2015-12-08

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAMA Inter Med：研究质疑心脏搭桥手术前使用β受体阻滞剂的作用

2015-03-08

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Gastroenterology：非选择性β受体阻滞剂可能增加自发性细菌性腹膜炎的肝硬化患者的死亡风险

2015-05-12

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Lancet：欧洲心脏病学会β受体阻滞剂使用推荐受挑战

2014-10-01

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

CCQO：β受体阻滞剂对冠心病患者没有明显临床疗效

2015-06-11

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

孙宁玲：如何看待“JNC 8”对β受体阻滞剂的不同意见？

2014-12-09

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

郭艺芳：β受体阻滞剂不会走下神坛

2015-02-11

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Chest：荟萃分析显示哮喘患者可有选择地使用β受体阻滞剂

2014-10-06

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

黄峻：JNC8不能否认β受体阻滞剂的“中国特色”

2014-08-16

智慧医人 (审核中...)

前往app查看评论内容

#受体阻滞剂#

2013 β受体阻滞剂在高血压应用中的专家指导建议

2013-11-05

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAMA Intern Med：行非心脏手术的缺血性心脏病患者应用β受体阻滞剂的疗效

2013-11-30

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAMA：非心脏手术围手术期使用β-受体阻滞剂或可降低患者死亡率

2013-05-28

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

β受体阻滞剂不影响慢性肾病死亡率

2013-03-07

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

SLEEP：褪黑素可改善高血压患者应用β受体阻滞剂相关失眠

2013-04-22

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性

2013-08-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

对于高血压患者β受体阻滞剂可减少阿尔茨海默型脑损伤

2013-04-12

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

β受体阻滞剂有待深入研究

2012-07-01

科室
- - 订阅+
  - 更多科室
工具
服务